Zobrazeno 1 - 10
of 338
pro vyhledávání: '"Hans A. Messner"'
Autor:
Jeffrey H. Lipton, Hans A. Messner, Katherine Siminovitch, Xiangdong Liu, Suzanne Kamel-Reid, Wei Xu, Lakshmi Sriharsha, Dong Hwan (Dennis) Kim
Purpose: Imatinib resistance is major cause of imatinib mesylate (IM) treatment failure in chronic myeloid leukemia (CML) patients. Several cellular and genetic mechanisms of imatinib resistance have been proposed, including amplification and overexp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a3b6b8a157adb8ebebb8cc641d697f2
https://doi.org/10.1158/1078-0432.c.6517617
https://doi.org/10.1158/1078-0432.c.6517617
Autor:
Jeffrey H. Lipton, Hans A. Messner, Katherine Siminovitch, Xiangdong Liu, Suzanne Kamel-Reid, Wei Xu, Lakshmi Sriharsha, Dong Hwan (Dennis) Kim
Supplementary Data from Clinical Relevance of a Pharmacogenetic Approach Using Multiple Candidate Genes to Predict Response and Resistance to Imatinib Therapy in Chronic Myeloid Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::757decf5518ce3e5ec1bb390d9b3cafd
https://doi.org/10.1158/1078-0432.22440264.v1
https://doi.org/10.1158/1078-0432.22440264.v1
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 13, Iss 4, Pp 220-231 (2020)
Objective/Background Patients in need of hematopoietic stem cell transplantation often cannot find a suitable HLA-matched donor in their families and rely on unrelated donors. Individuals can register with their country’s donor registry either onli
Autor:
Fotios V. Michelis, Santhosh Thyagu, Alexander Js Bacopoulos, Lina Ho, David Loach, Celina Dara, Anjie Yang, Pamela Ng, Hans A. Messner, Jeffrey H. Lipton, Dennis Dong Hwan Kim, Uday Deotare, Auro Viswabandya
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:33-39
At our institution, tacrolimus is used as a second-line agent for the prevention and treatment of graft-versus-host-disease in the allogeneic hematopoietic stem cell transplantation (HSCT) unit after patients have experienced a serious or intolerable
Autor:
Hans A. Messner, Jennifer A. H. Bell, Zoe Schmilovich, Judy Costello, Daniel Z. Buchman, Marnie Escaf
Publikováno v:
Healthcare Policy
Medical advancements have now made it possible to provide allogeneic stem cell transplantation (allo-SCTs) to older patients and use stem cells from less well-matched donors. This has resulted in access to a life-saving modality for a greater number
Autor:
J. Charles Victor, John Kuruvilla, Fotios V. Michelis, Dennis Dong Hwan Kim, Jeffrey H. Lipton, Doris Howell, Samantha J Mayo, Vikas Gutpa, Kelly A. Metcalfe, Sean B. Rourke, Hans A. Messner
Publikováno v:
Bone Marrow Transplantation. 55:918-928
Certain subgroups of patients may be particularly vulnerable to cognitive decline after treatment with allogeneic hematopoietic stem cell transplant (HCT). The objective of this study was to identify predictors of cognitive functioning changes within
Autor:
Rajat Kumar, Fotios V. Michelis, Elizabeth Shin, Jeffrey H. Lipton, Auro Viswabandya, Dennis Dong Hwan Kim, Jonas Mattsson, Arjun Datt Law, Wilson Lam, Roman M Shapiro, Hans A. Messner
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:1761-1769
The Centre for International Blood and Marrow Transplant Registry (CIBMTR) score has been shown to be prognostic for overall survival (OS) and nonrelapse mortality (NRM) but has been shown in several single-center studies to classify a large proporti
Autor:
Fotios V. Michelis, Rajat Kumar, Hans A. Messner, Arjun Datt Law, Maria Queralt Salas, Santhosh Thyagu, Jeffrey H. Lipton, Dennis Dong Hwan Kim, Auro Viswabandya, Wilson Lam
Publikováno v:
Biology of Blood and Marrow Transplantation
Highlights • HaploHSCT after RIC with ATG, PTCy, and cyclosporine is a feasible transplant regimen. • Low rates of grade II to IV acute GVHD were observed. • ATG use leads to higher rates of viral reactivation, particularly CMV and EBV.
Ha
Ha
Autor:
Uday Deotare, Jeffrey H Lipton, Santhosh Thyagu, Hans A. Messner, Dennis Dong Hwan Kim, Manar M I Khalil, Auro Viswabandya, Fotios V. Michelis
Publikováno v:
Annals of Hematology. 97:1975-1985
We have been using a combination of fludarabine/busulfan plus low-dose total body irradiation (TBI) as the reduced-intensity conditioning (RIC) regimen for patients age ≥ 60 years undergoing allogeneic hematopoietic cell transplantation (HCT) for m
Autor:
Kenneth Mah, Anargyros Xenocostas, Gerald M. Devins, Hans A. Messner, Lise Gauvin, Jeffrey H. Lipton
Publikováno v:
Supportive Care in Cancer. 26:2379-2386
Allogeneic hematopoietic cell transplantation (HCT) affects quality of life (QOL). Patient-reported outcomes examine symptoms, side effects, distress, and physical and social problems, but positive outcomes have been ignored. This inception cohort st